Proteasomal function is impaired in substantia nigra in Parkinson's disease

KSP McNaught, P Jenner - Neuroscience letters, 2001 - Elsevier
KSP McNaught, P Jenner
Neuroscience letters, 2001Elsevier
The accumulation of α-synuclein, ubiquitin and other proteins in Lewy bodies in
degenerating dopaminergic neurones in substantia nigra in idiopathic Parkinson's disease
(PD) suggest that inhibition of normal/abnormal protein degradation may contribute to
neuronal death. We now show for the first time that the chymotrypsin-(39%), trypsin-(42%)
and postacidic-like (33%) hydrolysing activities of 20/26S proteasome are impaired in
substantia nigra in PD. Proteasome inhibition does not appear to result from drug treatment …
The accumulation of α-synuclein, ubiquitin and other proteins in Lewy bodies in degenerating dopaminergic neurones in substantia nigra in idiopathic Parkinson's disease (PD) suggest that inhibition of normal/abnormal protein degradation may contribute to neuronal death. We now show for the first time that the chymotrypsin- (39%), trypsin- (42%) and postacidic-like (33%) hydrolysing activities of 20/26S proteasome are impaired in substantia nigra in PD. Proteasome inhibition does not appear to result from drug treatment since high concentrations of l-3,4-dihydroxyphenylalanine had no effect on enzymatic activity in vitro. These observations provide the first direct evidence that inhibition of the ubiquitin-proteasome pathway leading to altered protein handling and Lewy body formation may be responsible for degeneration of the nigrostriatal pathway in idiopathic PD.
Elsevier